The ESGCT Congress is an annual event organized by the European Society of Gene & Cell Therapy, serving as a premier platform for researchers, clinicians, and industry leaders to share the latest advancements in gene and cell therapy. The congress focuses on cutting-edge scientific research, clinical applications, and technological innovations in the field, aiming to accelerate the development of therapies for genetic and acquired diseases.
Key components of the ESGCT Congress include plenary sessions, workshops, and poster presentations covering topics such as gene editing, stem cell research, immunotherapies, and regulatory and ethical considerations. The event also provides opportunities for networking, fostering collaboration across academia, healthcare, and the biopharmaceutical industry. By bringing together experts from around the world, the ESGCT Congress plays a vital role in shaping the future of gene and cell therapy.
